Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 7/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 6/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 6/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.50 |
| ▸ | GRIN2C | Q14957 | 6/20 | 0.50 |
| ▸ | GRIN3A | Q8TCU5 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | STAT6 | P42226 | 1/20 | 0.50 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8720366 | 0.81 | GRIN1 (0.65) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL510762 | 0.81 | GRIN1 (0.65) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL12130587 | 0.81 | GRIN1 (0.65) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL14175431 | 0.81 | GRIN2D (0.33) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL12132159 | 0.81 | GRIN1 (0.65) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL9914296 | 0.81 | GRIN1 (0.65) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| Water SCHEMBL28015899 | 0.78 | GRIN1 (0.61) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL1880961 | 0.78 | LMNA (0.67) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL866896 | 0.78 | LMNA (0.67) | PKMGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL1362423 | 0.74 | PKM (0.56) | PKMGRIN1GRIN2AGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496112-A | Hydrogen-bond-induction-based metal-free molecular ferroelectric material and preparation method and application thereof | 东南大学 | 2024-08-16 | — | — | CN | claimed |
| CN-118496112-A | Hydrogen-bond-induction-based metal-free molecular ferroelectric material and preparation method and application thereof | 东南大学 | 2024-08-16 | — | — | CN | disclosed |
| US-20230161252-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20230161255-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| US-8440720-B2 | Methods of use of antiviral compounds | INFLUMEDIX, INC. (US) | 2013-05-14 | — | — | US | disclosed |
| US-8440720-B2 | Methods of use of antiviral compounds | INFLUMEDIX, INC. (US) | 2013-05-14 | — | — | US | disclosed |
| US-20110065766-A1 | METHODS OF USE OF ANTIVIRAL COMPOUNDS | INFLUMEDIX, INC. | 2011-03-17 | — | — | US | disclosed |
| US-20110065766-A1 | METHODS OF USE OF ANTIVIRAL COMPOUNDS | INFLUMEDIX, INC. | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065766-A1 | METHODS OF USE OF ANTIVIRAL COMPOUNDS | MAVS, SLC30A5, HAVCR2 | PKM 2637/4885GRIN1 2482/4885GRIN2A 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.